Theratechnologies Stock Quote THTX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.18

Bid

0.105

Ask

1.22

Volume

14,992

1.1799 Day's Range 1.20

1.08 52 Week Range 2.58

Market Cap

54.256M

Previous Close

1.21

Open

1.19

Last Trade

1.13

Last Trade Time

Financial Volume

$ 17,766

VWAP

1.185

Average Volume (3m)

35,429

Shares Outstanding

45,980,019

Dividend Yield

PE Ratio

-2.26

Earnings Per Share (EPS)

-0.52

Revenue

81.76M

Net Profit

-23.96M

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.theratech.com

Headquarters

Quebec City, Quebec, Can

Founded

Theratechnologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker THTX. The last closing price for Theratechnologies was $1.21. Over the last year, Theratechnologies shares have traded in a share price range of $ 1.08 to $ 2.58.

Theratechnologies currently has 45,980,019 shares outstanding. The market capitalization of Theratechnologies is $55.64 million. Theratechnologies has a price to earnings ratio (PE ratio) of -2.26.

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV

MONTREAL, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on development and...

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

MONTREAL, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on development and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024

Q3 revenue of $22.6 million represents +8% growth year-over-yearPositive net income of $3.1 million or 6 cents per share, and Adjusted EBITDA1 of $7.2 million Fiscal 2024 guidance revised to...

U.S. Futures Fall Slightly as Investors Await CPI Data; Oil Prices Rise

U.S. index futures dipped slightly in premarket trading on Thursday, following gains in the previous session, as investors await September’s CPI data, which could influence Federal Reserve...

Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV

MONTREAL, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on development and...

Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update

MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.11	-8.52713178295	1.29	1.29	1.18	33633	1.2487716	CS
4	-0.09	-7.08661417323	1.27	1.47	1.15	32216	1.27007677	CS
12	-0.11	-8.52713178295	1.29	1.47	1.15	35429	1.2528597	CS
26	-0.1	-7.8125	1.28	1.74	1.15	35543	1.3456294	CS
52	-0.17	-12.5925925926	1.35	2.58	1.08	54754	1.53225627	CS
156	-12.98	-91.6666666667	14.16	14.6	0.88	115021	4.80897775	CS
260	-13.22	-91.8055555556	14.4	17.8396	0.88	152475	8.3847081	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	$ 0.44 (25.71%)	140.02M